Master Protocol for the Phase 1 Study of Cell Therapies in Multiple Myeloma
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Relapsed and Refractory Multiple Myeloma
Age: Between 18 - 100 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required